Evidence map›Paper›PMID 39915832›Full record

ArticleCNS neuroscience & therapeutics2025

Hybrid PET/MRI Imaging of 18F-Fluorodeoxyglucose and 18-kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy.

Siqi Zhang, Jie Hu, Zhigang Qi, Chenyang Yao, Bixiao Cui, Jingjuan Wang, Zhenming Wang, Jie Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siqi ZhangDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.ORCID 0000-0002-1382-0708
Jie HuDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.ORCID 0000-0003-3210-5889
Zhigang QiDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Chenyang YaoDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Bixiao CuiDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Jingjuan WangDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Zhenming WangDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
Jie LuDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.ORCID 0000-0003-0425-3921

Funding

National Key Research and Development Program of China 2022YFC2406900National Key Research and Development Program of China 2022YFC2406904
6 · The paper itself

Abstract

purposeSurgery remains the only curative option for a third of refractory epilepsy patients, though success depends on precise localization of the epileptogenic zone (EZ). This study aims to assess the clinical value of hybrid

methodsThe refractory epilepsy patients who underwent surgery at Xuanwu Hospital from November 2022 to November 2023 were retrospectively recruited. Preoperative simultaneous

resultsA total of 43 patients (mean age: 26.30 ± 8.37 years, male: 28) were included in this study. Lesion localization accuracy within the EZ was 76.7% for

conclusion

Indexed as

Drug Resistant EpilepsyFluorodeoxyglucose F18Magnetic Resonance ImagingPositron-Emission TomographyReceptors, GABAAdolescentAdultFemaleHumansMaleMultimodal ImagingPreoperative CareRadiopharmaceuticalsRetrospective StudiesYoung AdultFluorodeoxyglucose F18RadiopharmaceuticalsReceptors, GABATSPO protein, humanfluorodeoxyglucosePET/MRIrefractory epilepsytranslocator protein 18 kDa

Identifiers

PMID39915832
PMCPMC11802325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.